Table 1 Comparison of tumor-related characteristics and clinical data between the Milan ~ Hangzhou and PLR < 120 and Milan ~ Hangzhou and PLR ≥ 120 groups
Variables | Milan ~ Hangzhou group | P value | |
|---|---|---|---|
PLR < 120 (n = 40) | PLR ≥ 120 (n = 9) | ||
Age (years) | 50.5 ± 8.4 | 51.3 ± 11.2 | 0.802 |
Gender (Male) | 36 (90.0%) | 7 (77.8%) | 0.302 |
MELD score | 12.6 ± 4.6 | 10.4 ± 2.5 | 0.062 |
AFP (ng/ml) | 675.1 ± 1282.9 | 1248.0 ± 2808.1 | 0.565 |
HBV infection | 37 (92.5%) | 7 (77.8%) | 0.224 |
Blood cell count (*109/L) | |||
 Neutrophil | 2.1 ± 1.4 | 2.4 ± 2.3 | 0.740 |
 Lymphocyte | 1.1 ± 0.7 | 0.7 ± 0.4 | 0.089 |
 Platelet | 84.0 ± 64.4 | 153.2 ± 108.5 | 0.098 |
Pre-LT treatment | |||
 Surgical resection | 5 (12.5%) | 4 (44.4%) | 0.046 |
 Interventional therapy | 18 (45.0%) | 8 (88.9%) | 0.026 |
Types of LT | Â | Â | 1.000 |
 LDLT | 3 (7.5%) | 0 (0.0%) |  |
 DDLT | 37 (92.5%) | 9 (100.0%) |  |
Solitary tumor | 19 (47.5%) | 6 (66.7%) | 0.463 |
Maximal tumor ≥ 7 cm | 7 (17.5%) | 5 (55.6%) | 0.029 |
Well-moderate differentiation | 28 (70.0%) | 8 (88.9%) | 0.412 |
Microvascular invasion | 8 (20.0%) | 1 (11.1%) | 1.000 |